Copyright
©The Author(s) 2020.
World J Gastroenterol. Aug 21, 2020; 26(31): 4589-4606
Published online Aug 21, 2020. doi: 10.3748/wjg.v26.i31.4589
Published online Aug 21, 2020. doi: 10.3748/wjg.v26.i31.4589
Figure 2 Cumulative drug release of different biliary drug-eluting stents with different drug-loading ratios.
A: Release curves of gemcitabine from PLCL-GEM-eluting stents; B: Release curves of cisplatin from PLCL-CIS-eluting stents; C: Release curves of (a) gemcitabine and (b) cisplatin from PLCL-GEM and CIS-eluting stents. CIS: Cisplatin; GEM: Gemcitabine; PLCL: Poly-L-lactide-caprolactone.
- Citation: Xiao JB, Weng JY, Hu YY, Deng GL, Wan XJ. Feasibility and efficacy evaluation of metallic biliary stents eluting gemcitabine and cisplatin for extrahepatic cholangiocarcinoma. World J Gastroenterol 2020; 26(31): 4589-4606
- URL: https://www.wjgnet.com/1007-9327/full/v26/i31/4589.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i31.4589